Role of tumor invasiveness, the extracellular matrix, and chromatin sequestration in the susceptibility of uveal melanoma to herpes simplex virus type 1

Experimental Eye Research

Volumn 84, Issue 5, 2007, Pages 991-1000

  Valyi Nagy, Klara ^a   Folberg, Robert ^a   Valyi Nagy, Tibor ^a   Maniotis, Andrew J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

chromatin exposure; chromatin sequestration; extracellular matrix; herpes simplex virus; laminin; oncolytic therapy; uveal melanoma

Indexed keywords

LAMININ; MATRIGEL; PROTEIN; VIRUS DNA;

ARTICLE; CANCER INVASION; CANCER RESISTANCE; CHOROID MELANOMA; CHROMATIN; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; VIRUS CELL INTERACTION;

CELL DEATH; CHROMATIN; COLLAGEN; DISEASE SUSCEPTIBILITY; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; LAMININ; MELANOMA; NEOPLASM INVASIVENESS; ONCOLYTIC VIROTHERAPY; PROTEOGLYCANS; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS; VIRULENCE;

EID: 34247161379     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.01.023     Document Type: Article

References (40)

1. Bedows E., Rao K.M., and Welsh M.J. Fate of microfilaments in Vero cells infected with measles virus and herpes simplex virus type 1. Mol. Cell Biol. 3 (1983) 712-719
2. Everett R.D., and Maul G.G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13 (1994) 5062-5069
3. Everett R.D., and Murray J. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79 (2005) 5078-5089
4. Folberg R., Hendrix M.J., and Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 156 (2000) 361-381
5. Folberg R., Arbieva Z., Moses J., Hayee A., Sandal T., Kadkol S., Lin A.K., Valyi-Nagy K., Setty S., Leach L., Chavez-Barrios P., Larsen P., Mujamdar D., Pe'er J., and Maniotis A.J. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Am. J. Pathol. 169 (2006) 1376-1389
6. Fortunato A., and Spector D.H. Viral induction of site-specific chromosome damage. Rev. Med. Virol. 13 (2003) 21-37
7. Gu H., Liang Y., Mandel G., and Roizman B. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl. Acad. Sci. USA. 102 (2005) 7571-7576
8. Hsie A.W., and Puck T.T. Morphologic transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3′.5′-monophosphate and testosterone. Proc. Natl. Acad. Sci. USA. 68 (1971) 358-361
9. Hobbs II W.E., and DeLuca N.A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 73 10 (1999) 8245-8255
10. Khodarev N.N., Advani S.J., Gupta N., Roizman B., and Weichselbaum R.R. Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc. Natl. Acad. Sci. USA. 96 21 (1999) 12062-12067
11. Krystosek A., and Puck T.T. The special distribution of exposed nuclear DNA in normal, cancer, and reverse-transformed cells. Proc. Natl. Acad. Sci. USA. 87 (1990) 6560-6564
12. Latchman D.S. Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease. Curr. Opin. Mol. Ther. 7 (2005) 415-418
13. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M.G., Pe'er J., Trent J.M., Meltzer P.S., and Hendrix M.J.C. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155 (1999) 739-752
14. Maniotis A.J., Valyi-Nagy K., Karavitis J., Moses J., Boddipali J.V., Wang Y., Nuñez R., Setty S., Bissell M.J., and Folberg R. Chromatin organization measured by AluI restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton. Am. J. Pathol. 166 (2005) 1187-1203
15. Maul G.G., and Everett R.D. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75 (1994) 1223-1233
16. Maul G.G., Guldner H.H., and Spivack J.G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene product. J. Gen. Virol. 74 (1993) 2679-2690
17. MacKie R.M., Stewart B., and Brown S.M. Intralesional injection of herpes simplex virus 1716 in metastatic melanoma. Lancet 357 (2001) 525-526
18. McKie T.D., Grandi P., Mok W., Alexandrakis G., Insin N., Zimmer J.P., Bawaendi M.G., Boucher Y., Breakefield X.O., and Jain R.K. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res. 66 (2006) 2509-2513
19. Miller C.G., and Fraser N.W. Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model. Mol. Ther. 7 (2003) 741-747
20. Murata T., Goshima F., Daikoku T., Takakuwa H., and Nishiyama Y. Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 5 (2000) 1017-1027
21. Namkoong J., Martino J.J., and Chen S. From existing therapies to novel targets: a current view of melanoma. Front. Biosci. 11 (2006) 2081-2092
22. Puck T.T., Krystosek A., and Chan D.C. Genome regulation in mammalian cells. Somat. Cell. Mol. Genet. 16 (1990) 257-265
23. Randazzo B.P., Kesari S., Gesser R.M., Alsop D., Ford J.C., Brown S.M., McLean A., and Fraser N.W. Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology 211 (1995) 94-101
24. Randazzo B.P., Bhat M.G., Kesari S., Fraser N.W., and Brown S.M. Treatment of experimental subcutaneous melanoma with a replication-restricted herpes simplex virus mutant. J. Invest. Dermatol. 108 (1997) 933-937
25. Roizman B., and Knipe D.M. Herpes simplex viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott Williams and Wilkins, Philadelphia 2399-2459
26. Roizman B., and Pellet P.E. The family of Herpesviridae: a brief introduction. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott Williams and Wilkins, Philadelphia 2381-2397
27. Roizman B., Gu H., and Mandel G. The first 30 min in the life of a virus: unrest in the nucleus. Cell Cycle 4 (2005) 8
28. Shen Y., and Nemunaitis J. Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Ther. 13 11 (2006) 975-992
29. Simpson-Holey M., Colgrove R.C., Nalepa G., Harper J.G., and Knipe D.M. Identification and functional evaluation of cellular and viral factors involved in the alteration of nuclear architecture during herpes simplex virus 1 infection. J. Virol. 79 (2005) 12840-12851
30. Stein G.S. Mechanogenomic control of DNA exposure and sequestration. Am. J. Pathol. 166 4 (2005) 959-962
31. Stingley S.W., Ramirez J.J., Aguilar S.A., Simmen K., Sandi-Goldin R.M., Ghazal P., and Wagner E.K. Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J. Virol. 74 21 (2000) 9916-9927
32. Taddeo B., Esclatine A., and Roizman B. The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene. Proc. Natl. Acad. Sci. USA. 99 26 (2002) 17031-17036
33. Toda M., Rabkin S.D., Kojima H., and Martuza R.L. Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum. Gene Ther. 10 (1999) 385-393
34. Valyi-Nagy T., Deshmane S.L., Dillner A.J., and Fraser N.W. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, HSV-1 infection and explantation of trigeminal ganglia. J. Virol. 65 (1991) 4142-4152
35. Valyi-Nagy T., Shukla D., Engelhard H.H., Kavouras J., and Scanlan P. Latency strategies of alphaherpesviruses: herpes simplex virus and varicella-zoster virus latency in neurons. In: Minarovits J., Gonczol E., and Valyi-Nagy T. (Eds). Latency Strategies of Herpesviruses (2007), Springer, New York 1-36
36. Varghese S., and Rabkin S.D. Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther. 9 (2002) 967-978
37. Ward P.L., Avitabile E., Campadelli-Fiume G., and Roizman B. Conservation of the architecture of the Golgi apparatus related to a differential organization of microtubules in polykaryocytes induced by syn-mutants of herpes virus type 1. Virology. 241 (1998) 189-199
38. Weintraub H., and Goudine M. Chromosomal subunits in active genes have an altered conformation. Science 193 (1976) 848-856
39. Winkler M., Dawson G.J., Elizan T.S., and Berl S. Distribution of actin and myosin in a rat neuronal cell line infected with herpes simplex virus. Arch. Virol. 72 (1982) 95-103
40. Woll E., Bedikian A., and Legha S.S. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 9 (1999) 575-581